$EYPT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in EyePoint Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in EyePoint Pharmaceuticals, Inc.. Get notifications about new insider transactions in EyePoint Pharmaceuticals, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 23 2021 | EYPT | EyePoint Pharmaceu ... | Paggiarino Dario A. | Chief Medical Offic ... | Option Exercise | A | 13.13 | 60,300 | 791,739 | 60,300 | |
| Jun 23 2021 | EYPT | EyePoint Pharmaceu ... | Paggiarino Dario A. | Chief Medical Offic ... | Option Exercise | A | 0.00 | 14,900 | 0 | 14,900 | |
| Jun 23 2021 | EYPT | EyePoint Pharmaceu ... | Elston George | Chief Financial Off ... | Option Exercise | A | 13.13 | 60,300 | 791,739 | 60,300 | |
| Jun 23 2021 | EYPT | EyePoint Pharmaceu ... | Elston George | Chief Financial Off ... | Option Exercise | A | 0.00 | 14,900 | 0 | 14,900 | |
| Feb 23 2021 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Option Exercise | M | 0.00 | 13,717 | 0 | 13,718 | |
| Feb 23 2021 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Buy | M | 0.00 | 13,717 | 0 | 96,579 | 82.9 K to 96.6 K (+16.55 %) |
| Sep 09 2020 | EYPT | EyePoint Pharmaceu ... | Elston George | Chief Financial Off ... | Buy | P | 0.48 | 10,000 | 4,800 | 40,000 | 30 K to 40 K (+33.33 %) |
| Aug 26 2020 | EYPT | EyePoint Pharmaceu ... | Elston George | Chief Financial Off ... | Buy | P | 0.61 | 10,000 | 6,112 | 30,000 | 20 K to 30 K (+50.00 %) |
| Jul 02 2020 | EYPT | EyePoint Pharmaceu ... | Jones David Scott | SVP & Chief Commerc ... | Option Exercise | M | 0.00 | 41,050 | 0 | 82,100 | |
| Jul 02 2020 | EYPT | EyePoint Pharmaceu ... | Jones David Scott | SVP & Chief Commerc ... | Payment of Exercise | F | 0.76 | 14,060 | 10,643 | 26,990 | 41.1 K to 27 K (-34.25 %) |
| Jul 02 2020 | EYPT | EyePoint Pharmaceu ... | Jones David Scott | SVP & Chief Commerc ... | Buy | M | 0.00 | 41,050 | 0 | 41,050 | 0 to 41.1 K |
| Jul 02 2020 | EYPT | EyePoint Pharmaceu ... | Paggiarino Dario A. | Chief Medical Offic ... | Option Exercise | M | 0.00 | 41,050 | 0 | 82,100 | |
| Jul 02 2020 | EYPT | EyePoint Pharmaceu ... | Paggiarino Dario A. | Chief Medical Offic ... | Payment of Exercise | F | 0.76 | 12,049 | 9,121 | 89,144 | 101.2 K to 89.1 K (-11.91 %) |
| Jul 02 2020 | EYPT | EyePoint Pharmaceu ... | Paggiarino Dario A. | Chief Medical Offic ... | Buy | M | 0.00 | 41,050 | 0 | 101,193 | 60.1 K to 101.2 K (+68.25 %) |
| Jul 02 2020 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Option Exercise | M | 0.00 | 124,667 | 0 | 249,333 | |
| Jul 02 2020 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Buy | M | 0.00 | 124,667 | 0 | 784,467 | 659.8 K to 784.5 K (+18.89 %) |
| Jun 30 2020 | EYPT | EyePoint Pharmaceu ... | Paggiarino Dario A. | Chief Medical Offic ... | Option Exercise | M | 0.00 | 10,000 | 0 | 0 | |
| Jun 30 2020 | EYPT | EyePoint Pharmaceu ... | Paggiarino Dario A. | Chief Medical Offic ... | Payment of Exercise | F | 0.79 | 2,936 | 2,317 | 60,143 | 63.1 K to 60.1 K (-4.65 %) |
| Jun 30 2020 | EYPT | EyePoint Pharmaceu ... | Paggiarino Dario A. | Chief Medical Offic ... | Buy | M | 0.00 | 10,000 | 0 | 63,079 | 53.1 K to 63.1 K (+18.84 %) |
| Jun 30 2020 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Option Exercise | M | 0.00 | 40,000 | 0 | 0 | |
| Jun 30 2020 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Buy | M | 0.00 | 40,000 | 0 | 659,800 | 619.8 K to 659.8 K (+6.45 %) |
| Jun 16 2020 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Option Exercise | M | 0.00 | 45,000 | 0 | 45,000 | |
| Jun 16 2020 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Buy | M | 0.00 | 45,000 | 0 | 619,800 | 574.8 K to 619.8 K (+7.83 %) |
| Jun 16 2020 | EYPT | EyePoint Pharmaceu ... | Paggiarino Dario A. | Chief Medical Offic ... | Option Exercise | M | 0.00 | 14,200 | 0 | 14,200 | |
| Jun 16 2020 | EYPT | EyePoint Pharmaceu ... | Paggiarino Dario A. | Chief Medical Offic ... | Payment of Exercise | F | 0.83 | 4,168 | 3,441 | 53,079 | 57.2 K to 53.1 K (-7.28 %) |
| Jun 16 2020 | EYPT | EyePoint Pharmaceu ... | Paggiarino Dario A. | Chief Medical Offic ... | Buy | M | 0.00 | 14,200 | 0 | 57,247 | 43 K to 57.2 K (+32.99 %) |
| Mar 13 2020 | EYPT | EyePoint Pharmaceu ... | Elston George | Chief Financial Off ... | Buy | P | 0.96 | 10,000 | 9,600 | 20,000 | 10 K to 20 K (+100.00 %) |
| Mar 11 2020 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Buy | P | 1.06 | 98,000 | 104,027 | 574,800 | 476.8 K to 574.8 K (+20.55 %) |
| Nov 18 2019 | EYPT | EyePoint Pharmaceu ... | Elston George | Chief Financial Off ... | Option Exercise | A | 1.42 | 745,000 | 1,057,900 | 745,000 | |
| Nov 18 2019 | EYPT | EyePoint Pharmaceu ... | Elston George | Chief Financial Off ... | Option Exercise | A | 1.42 | 745,000 | 1,057,900 | 745,000 | |
| Nov 18 2019 | EYPT | EyePoint Pharmaceu ... | Elston George | Chief Financial Off ... | Buy | P | 1.43 | 10,000 | 14,290 | 10,000 | 0 to 10 K |
| Nov 18 2019 | EYPT | EyePoint Pharmaceu ... | Elston George | Chief Financial Off ... | Buy | P | 1.43 | 10,000 | 14,290 | 10,000 | 0 to 10 K |
| Oct 15 2019 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Payment of Exercise | F | 2.11 | 10,745 | 22,618 | 314,455 | 325.2 K to 314.5 K (-3.30 %) |
| Oct 15 2019 | EYPT | EyePoint Pharmaceu ... | Paggiarino Dario A. | Chief Medical Offic ... | Payment of Exercise | F | 2.11 | 2,450 | 5,157 | 43,047 | 45.5 K to 43 K (-5.38 %) |
| Oct 11 2019 | EYPT | EyePoint Pharmaceu ... | Mazzo David J | Option Exercise | M | 1.95 | 33,333 | 64,999 | 0 | ||
| Oct 11 2019 | EYPT | EyePoint Pharmaceu ... | Mazzo David J | Buy | M | 1.95 | 33,333 | 64,999 | 200,083 | 166.8 K to 200.1 K (+19.99 %) | |
| Sep 10 2019 | EYPT | EyePoint Pharmaceu ... | Mazzo David J | Option Exercise | M | 0.00 | 417 | 0 | 0 | ||
| Sep 10 2019 | EYPT | EyePoint Pharmaceu ... | Mazzo David J | Buy | M | 0.00 | 417 | 0 | 166,750 | 166.3 K to 166.8 K (+0.25 %) | |
| Jul 16 2019 | EYPT | EyePoint Pharmaceu ... | DICICCO WENDY F | Option Exercise | A | 1.51 | 80,000 | 120,800 | 80,000 | ||
| Jun 28 2019 | EYPT | EyePoint Pharmaceu ... | Ross Leonard S | See Remarks | Option Exercise | M | 0.00 | 6,667 | 0 | 6,667 | |
| Jun 28 2019 | EYPT | EyePoint Pharmaceu ... | Ross Leonard S | See Remarks | Payment of Exercise | F | 1.65 | 1,961 | 3,236 | 90,044 | 92 K to 90 K (-2.13 %) |
| Jun 28 2019 | EYPT | EyePoint Pharmaceu ... | Ross Leonard S | See Remarks | Buy | M | 0.00 | 6,667 | 0 | 92,005 | 85.3 K to 92 K (+7.81 %) |
| Jun 28 2019 | EYPT | EyePoint Pharmaceu ... | Paggiarino Dario A. | Chief Medical Offic ... | Option Exercise | M | 0.00 | 10,000 | 0 | 10,000 | |
| Jun 28 2019 | EYPT | EyePoint Pharmaceu ... | Paggiarino Dario A. | Chief Medical Offic ... | Payment of Exercise | F | 1.65 | 2,940 | 4,851 | 45,497 | 48.4 K to 45.5 K (-6.07 %) |
| Jun 28 2019 | EYPT | EyePoint Pharmaceu ... | Paggiarino Dario A. | Chief Medical Offic ... | Buy | M | 0.00 | 10,000 | 0 | 48,437 | 38.4 K to 48.4 K (+26.02 %) |
| Jun 28 2019 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Option Exercise | M | 0.00 | 40,000 | 0 | 40,000 | |
| Jun 28 2019 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Buy | M | 0.00 | 40,000 | 0 | 325,200 | 285.2 K to 325.2 K (+14.03 %) |
| Jun 27 2019 | EYPT | EyePoint Pharmaceu ... | ROGERS MICHAEL W | Option Exercise | A | 2.65 | 40,000 | 106,000 | 40,000 | ||
| Jun 27 2019 | EYPT | EyePoint Pharmaceu ... | Mazzo David J | Option Exercise | A | 2.65 | 40,000 | 106,000 | 40,000 | ||
| Jun 27 2019 | EYPT | EyePoint Pharmaceu ... | Duker Jay S. | Option Exercise | A | 2.65 | 40,000 | 106,000 | 40,000 | ||
| Jun 27 2019 | EYPT | EyePoint Pharmaceu ... | Landis John B. | Option Exercise | A | 2.65 | 40,000 | 106,000 | 40,000 | ||
| Jun 27 2019 | EYPT | EyePoint Pharmaceu ... | Godshall Douglas Evan | Option Exercise | A | 2.65 | 40,000 | 106,000 | 40,000 | ||
| Jun 27 2019 | EYPT | EyePoint Pharmaceu ... | Peterson Kristine | Option Exercise | A | 2.65 | 40,000 | 106,000 | 40,000 | ||
| Jun 27 2019 | EYPT | EyePoint Pharmaceu ... | ANDO GORAN | Option Exercise | A | 2.65 | 50,000 | 132,500 | 50,000 | ||
| Jun 27 2019 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Option Exercise | A | 2.65 | 930,000 | 2,464,500 | 930,000 | |
| Jun 27 2019 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Option Exercise | A | 2.65 | 930,000 | 2,464,500 | 930,000 | |
| Jun 27 2019 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Option Exercise | A | 0.00 | 411,523 | 0 | 411,523 | |
| Jun 27 2019 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Option Exercise | A | 0.00 | 411,523 | 0 | 411,523 | |
| Jun 27 2019 | EYPT | EyePoint Pharmaceu ... | Price David | CFO | Option Exercise | A | 2.65 | 300,000 | 795,000 | 300,000 | |
| Jun 27 2019 | EYPT | EyePoint Pharmaceu ... | Price David | CFO | Option Exercise | A | 2.65 | 300,000 | 795,000 | 300,000 | |
| Jun 27 2019 | EYPT | EyePoint Pharmaceu ... | Paggiarino Dario A. | Chief Medical Offic ... | Option Exercise | A | 2.65 | 370,000 | 980,500 | 370,000 | |
| Jun 27 2019 | EYPT | EyePoint Pharmaceu ... | Paggiarino Dario A. | Chief Medical Offic ... | Option Exercise | A | 2.65 | 370,000 | 980,500 | 370,000 | |
| Jun 24 2019 | EYPT | EyePoint Pharmaceu ... | ROGERS MICHAEL W | Option Exercise | M | 0.00 | 6,667 | 0 | 0 | ||
| Jun 24 2019 | EYPT | EyePoint Pharmaceu ... | ROGERS MICHAEL W | Buy | M | 0.00 | 6,667 | 0 | 119,167 | 112.5 K to 119.2 K (+5.93 %) | |
| Jun 24 2019 | EYPT | EyePoint Pharmaceu ... | Mazzo David J | Option Exercise | M | 0.00 | 8,333 | 0 | 0 | ||
| Jun 24 2019 | EYPT | EyePoint Pharmaceu ... | Mazzo David J | Buy | M | 0.00 | 8,333 | 0 | 166,333 | 158 K to 166.3 K (+5.27 %) | |
| Jun 24 2019 | EYPT | EyePoint Pharmaceu ... | Peterson Kristine | Option Exercise | M | 0.00 | 6,667 | 0 | 0 | ||
| Jun 24 2019 | EYPT | EyePoint Pharmaceu ... | Peterson Kristine | Buy | M | 0.00 | 6,667 | 0 | 6,667 | 0 to 6.7 K | |
| Jun 24 2019 | EYPT | EyePoint Pharmaceu ... | Godshall Douglas Evan | Option Exercise | M | 0.00 | 6,667 | 0 | 0 | ||
| Jun 24 2019 | EYPT | EyePoint Pharmaceu ... | Godshall Douglas Evan | Buy | M | 0.00 | 6,667 | 0 | 36,167 | 29.5 K to 36.2 K (+22.60 %) | |
| Jun 24 2019 | EYPT | EyePoint Pharmaceu ... | Duker Jay S. | Option Exercise | M | 0.00 | 6,667 | 0 | 0 | ||
| Jun 24 2019 | EYPT | EyePoint Pharmaceu ... | Duker Jay S. | Buy | M | 0.00 | 6,667 | 0 | 44,167 | 37.5 K to 44.2 K (+17.78 %) | |
| Jun 17 2019 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Option Exercise | M | 0.00 | 45,000 | 0 | 90,000 | |
| Jun 17 2019 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Buy | M | 0.00 | 45,000 | 0 | 285,200 | 240.2 K to 285.2 K (+18.73 %) |
| Jun 17 2019 | EYPT | EyePoint Pharmaceu ... | Ross Leonard S | See Remarks | Option Exercise | M | 0.00 | 8,280 | 0 | 16,560 | |
| Jun 17 2019 | EYPT | EyePoint Pharmaceu ... | Ross Leonard S | See Remarks | Payment of Exercise | F | 1.53 | 2,394 | 3,663 | 85,338 | 87.7 K to 85.3 K (-2.73 %) |
| Jun 17 2019 | EYPT | EyePoint Pharmaceu ... | Ross Leonard S | See Remarks | Buy | M | 0.00 | 8,280 | 0 | 87,732 | 79.5 K to 87.7 K (+10.42 %) |
| Jun 17 2019 | EYPT | EyePoint Pharmaceu ... | Paggiarino Dario A. | Chief Medical Offic ... | Option Exercise | M | 0.00 | 14,200 | 0 | 28,400 | |
| Jun 17 2019 | EYPT | EyePoint Pharmaceu ... | Paggiarino Dario A. | Chief Medical Offic ... | Payment of Exercise | F | 1.53 | 4,175 | 6,388 | 38,437 | 42.6 K to 38.4 K (-9.80 %) |
| Jun 17 2019 | EYPT | EyePoint Pharmaceu ... | Paggiarino Dario A. | Chief Medical Offic ... | Buy | M | 0.00 | 14,200 | 0 | 42,612 | 28.4 K to 42.6 K (+49.98 %) |
| Jun 12 2019 | EYPT | EyePoint Pharmaceu ... | Jones David Scott | SVP & Chief Commerc ... | Option Exercise | A | 1.47 | 350,000 | 514,500 | 350,000 | |
| May 15 2019 | EYPT | EyePoint Pharmaceu ... | Landis John B. | Buy | P | 1.74 | 40,000 | 69,600 | 40,000 | 0 to 40 K | |
| Apr 16 2019 | EYPT | EyePoint Pharmaceu ... | Duker Jay S. | Option Exercise | M | 1.77 | 20,000 | 35,400 | 0 | ||
| Apr 16 2019 | EYPT | EyePoint Pharmaceu ... | Duker Jay S. | Buy | M | 1.77 | 20,000 | 35,400 | 37,500 | 17.5 K to 37.5 K (+114.29 %) | |
| Apr 03 2019 | EYPT | EyePoint Pharmaceu ... | Duker Jay S. | Buy | P | 1.89 | 5,000 | 9,450 | 17,500 | 12.5 K to 17.5 K (+40.00 %) | |
| Apr 02 2019 | EYPT | EyePoint Pharmaceu ... | Ross Leonard S | See Remarks | Option Exercise | M | 1.81 | 5,000 | 9,050 | 0 | |
| Apr 02 2019 | EYPT | EyePoint Pharmaceu ... | Ross Leonard S | See Remarks | Buy | M | 1.81 | 5,000 | 9,050 | 79,452 | 74.5 K to 79.5 K (+6.72 %) |
| Apr 01 2019 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Buy | P | 1.76 | 28,500 | 50,246 | 240,200 | 211.7 K to 240.2 K (+13.46 %) |
| Apr 01 2019 | EYPT | EyePoint Pharmaceu ... | Mazzo David J | Option Exercise | M | 1.77 | 20,000 | 35,400 | 0 | ||
| Apr 01 2019 | EYPT | EyePoint Pharmaceu ... | Mazzo David J | Buy | M | 1.77 | 20,000 | 35,400 | 158,000 | 138 K to 158 K (+14.49 %) | |
| Apr 01 2019 | EYPT | EyePoint Pharmaceu ... | Godshall Douglas Evan | Buy | P | 1.75 | 17,000 | 29,784 | 29,500 | 12.5 K to 29.5 K (+136.00 %) | |
| Mar 21 2019 | EYPT | EyePoint Pharmaceu ... | Paggiarino Dario A. | Chief Medical Offic ... | Payment of Exercise | F | 2.47 | 1,188 | 2,934 | 28,412 | 29.6 K to 28.4 K (-4.01 %) |
| Mar 21 2019 | EYPT | EyePoint Pharmaceu ... | Ross Leonard S | See Remarks | Payment of Exercise | F | 2.47 | 1,735 | 4,285 | 74,452 | 76.2 K to 74.5 K (-2.28 %) |
| Jan 29 2019 | EYPT | EyePoint Pharmaceu ... | GUYER DAVID R | Option Exercise | A | 2.42 | 80,000 | 193,600 | 80,000 | ||
| Dec 26 2018 | EYPT | EyePoint Pharmaceu ... | Ross Leonard S | See Remarks | Option Exercise | M | 0.00 | 62,892 | 0 | 0 | |
| Dec 26 2018 | EYPT | EyePoint Pharmaceu ... | Ross Leonard S | See Remarks | Payment of Exercise | F | 1.65 | 18,522 | 30,561 | 76,187 | 94.7 K to 76.2 K (-19.56 %) |
| Dec 26 2018 | EYPT | EyePoint Pharmaceu ... | Ross Leonard S | See Remarks | Buy | M | 0.00 | 62,892 | 0 | 94,709 | 31.8 K to 94.7 K (+197.67 %) |
| Nov 16 2018 | EYPT | EyePoint Pharmaceu ... | ROGERS MICHAEL W | Director | Option Exercise | M | 1.13 | 100,000 | 113,000 | 0 | |
| Nov 16 2018 | EYPT | EyePoint Pharmaceu ... | ROGERS MICHAEL W | Director | Buy | M | 1.13 | 100,000 | 113,000 | 112,500 | 12.5 K to 112.5 K (+800.00 %) |
| Oct 29 2018 | EYPT | EyePoint Pharmaceu ... | Landis John B. | Director | Option Exercise | A | 2.27 | 80,000 | 181,600 | 80,000 | |
| Oct 16 2018 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Grant | A | 0.00 | 76,667 | 0 | 211,700 | 135 K to 211.7 K (+56.78 %) |
| Oct 16 2018 | EYPT | EyePoint Pharmaceu ... | Ross Leonard S | See Remarks | Payment of Exercise | F | 3.23 | 2,945 | 9,512 | 31,817 | 34.8 K to 31.8 K (-8.47 %) |
| Oct 16 2018 | EYPT | EyePoint Pharmaceu ... | Ross Leonard S | See Remarks | Grant | A | 0.00 | 20,000 | 0 | 34,762 | 14.8 K to 34.8 K (+135.48 %) |
| Oct 16 2018 | EYPT | EyePoint Pharmaceu ... | Paggiarino Dario A. | Chief Medical Offic ... | Payment of Exercise | F | 3.23 | 2,455 | 7,930 | 29,600 | 32.1 K to 29.6 K (-7.66 %) |
| Oct 16 2018 | EYPT | EyePoint Pharmaceu ... | Paggiarino Dario A. | Chief Medical Offic ... | Grant | A | 0.00 | 16,667 | 0 | 32,055 | 15.4 K to 32.1 K (+108.31 %) |
| Oct 15 2018 | EYPT | EyePoint Pharmaceu ... | ANDO GORAN | Director | Option Exercise | A | 3.06 | 15,000 | 45,900 | 15,000 | |
| Sep 10 2018 | PSDV | EyePoint Pharmaceu ... | Mazzo David J | Director | Option Exercise | A | 0.00 | 417 | 0 | 417 | |
| Sep 10 2018 | PSDV | EyePoint Pharmaceu ... | Mazzo David J | Director | Option Exercise | A | 2.32 | 1,667 | 3,867 | 1,667 | |
| Aug 03 2018 | PSDV | EyePoint Pharmaceu ... | Price David | Chief Financial Off ... | Option Exercise | A | 2.22 | 385,000 | 854,700 | 385,000 | |
| Jul 03 2018 | PSDV | EyePoint Pharmaceu ... | EW Healthcare Partners, L.P. | 10% Owner | Option Exercise | P | 0.00 | 652,244 | 0 | 16,864,066 | |
| Jul 03 2018 | PSDV | EyePoint Pharmaceu ... | EW Healthcare Partners, L.P. | 10% Owner | Option Exercise | P | 0.00 | 16,211,822 | 0 | 16,864,066 | |
| Jul 03 2018 | PSDV | EyePoint Pharmaceu ... | EW Healthcare Partners, L.P. | 10% Owner | Buy | P | 1.27 | 652,244 | 825,089 | 25,470,390 | 24.8 M to 25.5 M (+2.63 %) |
| Jul 03 2018 | PSDV | EyePoint Pharmaceu ... | EW Healthcare Partners, L.P. | 10% Owner | Buy | P | 1.27 | 16,211,822 | 20,507,955 | 25,470,390 | 9.3 M to 25.5 M (+175.10 %) |
| Jun 29 2018 | PSDV | EyePoint Pharmaceu ... | Duker Jay S. | Director | Option Exercise | M | 0.00 | 12,500 | 0 | 0 | |
| Jun 29 2018 | PSDV | EyePoint Pharmaceu ... | Duker Jay S. | Director | Buy | M | 0.00 | 12,500 | 0 | 12,500 | 0 to 12.5 K |
| Jun 29 2018 | PSDV | EyePoint Pharmaceu ... | Mazzo David J | Director | Option Exercise | M | 0.00 | 17,500 | 0 | 0 | |
| Jun 29 2018 | PSDV | EyePoint Pharmaceu ... | Mazzo David J | Director | Buy | M | 0.00 | 17,500 | 0 | 138,000 | 120.5 K to 138 K (+14.52 %) |
| Jun 29 2018 | PSDV | EyePoint Pharmaceu ... | Ross Leonard S | See Remarks | Option Exercise | M | 0.00 | 6,666 | 0 | 13,334 | |
| Jun 29 2018 | PSDV | EyePoint Pharmaceu ... | Ross Leonard S | See Remarks | Payment of Exercise | F | 1.86 | 1,904 | 3,541 | 14,762 | 16.7 K to 14.8 K (-11.42 %) |
| Jun 29 2018 | PSDV | EyePoint Pharmaceu ... | Ross Leonard S | See Remarks | Buy | M | 0.00 | 6,666 | 0 | 16,666 | 10 K to 16.7 K (+66.66 %) |
| Jun 29 2018 | PSDV | EyePoint Pharmaceu ... | Paggiarino Dario A. | Chief Medical Offic ... | Option Exercise | M | 0.00 | 10,000 | 0 | 20,000 | |
| Jun 29 2018 | PSDV | EyePoint Pharmaceu ... | Paggiarino Dario A. | Chief Medical Offic ... | Payment of Exercise | F | 1.86 | 2,945 | 5,478 | 15,388 | 18.3 K to 15.4 K (-16.06 %) |
| Jun 29 2018 | PSDV | EyePoint Pharmaceu ... | Paggiarino Dario A. | Chief Medical Offic ... | Buy | M | 0.00 | 10,000 | 0 | 18,333 | 8.3 K to 18.3 K (+120.00 %) |
| Jun 29 2018 | PSDV | EyePoint Pharmaceu ... | ROGERS MICHAEL W | Director | Option Exercise | M | 0.00 | 12,500 | 0 | 0 | |
| Jun 29 2018 | PSDV | EyePoint Pharmaceu ... | ROGERS MICHAEL W | Director | Buy | M | 0.00 | 12,500 | 0 | 12,500 | 0 to 12.5 K |
| Jun 29 2018 | PSDV | EyePoint Pharmaceu ... | Godshall Douglas Evan | Director | Option Exercise | M | 0.00 | 12,500 | 0 | 0 | |
| Jun 29 2018 | PSDV | EyePoint Pharmaceu ... | Godshall Douglas Evan | Director | Buy | M | 0.00 | 12,500 | 0 | 12,500 | 0 to 12.5 K |
| Jun 29 2018 | PSDV | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Option Exercise | M | 0.00 | 40,000 | 0 | 80,000 | |
| Jun 29 2018 | PSDV | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Buy | M | 0.00 | 40,000 | 0 | 135,033 | 95 K to 135 K (+42.09 %) |
| Jun 27 2018 | PSDV | EyePoint Pharmaceu ... | ANDO GORAN | Director | Option Exercise | A | 1.93 | 80,000 | 154,400 | 80,000 | |
| Jun 26 2018 | PSDV | EyePoint Pharmaceu ... | Peterson Kristine | Director | Option Exercise | A | 1.95 | 40,000 | 78,000 | 40,000 | |
| Jun 26 2018 | PSDV | EyePoint Pharmaceu ... | Peterson Kristine | Director | Option Exercise | A | 0.00 | 6,667 | 0 | 6,667 | |
| Jun 26 2018 | PSDV | EyePoint Pharmaceu ... | Peterson Kristine | Director | Option Exercise | A | 1.95 | 26,667 | 52,001 | 26,667 | |
| Jun 26 2018 | PSDV | EyePoint Pharmaceu ... | Duker Jay S. | Director | Option Exercise | A | 0.00 | 6,667 | 0 | 6,667 | |
| Jun 26 2018 | PSDV | EyePoint Pharmaceu ... | Duker Jay S. | Director | Option Exercise | A | 1.95 | 26,667 | 52,001 | 26,667 | |
| Jun 26 2018 | PSDV | EyePoint Pharmaceu ... | ROGERS MICHAEL W | Director | Option Exercise | A | 0.00 | 6,667 | 0 | 6,667 | |
| Jun 26 2018 | PSDV | EyePoint Pharmaceu ... | ROGERS MICHAEL W | Director | Option Exercise | A | 1.95 | 26,667 | 52,001 | 26,667 | |
| Jun 26 2018 | PSDV | EyePoint Pharmaceu ... | Godshall Douglas Evan | Director | Option Exercise | A | 0.00 | 6,667 | 0 | 6,667 | |
| Jun 26 2018 | PSDV | EyePoint Pharmaceu ... | Godshall Douglas Evan | Director | Option Exercise | A | 1.95 | 26,667 | 52,001 | 26,667 | |
| Jun 26 2018 | PSDV | EyePoint Pharmaceu ... | Mazzo David J | Director | Option Exercise | A | 0.00 | 8,333 | 0 | 8,333 | |
| Jun 26 2018 | PSDV | EyePoint Pharmaceu ... | Mazzo David J | Director | Option Exercise | A | 1.95 | 33,333 | 64,999 | 33,333 | |
| Jun 18 2018 | PSDV | EyePoint Pharmaceu ... | Paggiarino Dario A. | Chief Medical Offic ... | Option Exercise | A | 2.04 | 170,500 | 347,820 | 170,500 | |
| Jun 18 2018 | PSDV | EyePoint Pharmaceu ... | Paggiarino Dario A. | Chief Medical Offic ... | Option Exercise | A | 0.00 | 42,600 | 0 | 42,600 | |
| Jun 18 2018 | PSDV | EyePoint Pharmaceu ... | Lurker Nancy | President and CEO | Option Exercise | A | 2.04 | 540,000 | 1,101,600 | 540,000 | |
| Jun 18 2018 | PSDV | EyePoint Pharmaceu ... | Lurker Nancy | President and CEO | Option Exercise | A | 0.00 | 135,000 | 0 | 135,000 | |
| Jun 18 2018 | PSDV | EyePoint Pharmaceu ... | Ross Leonard S | See Remarks | Option Exercise | A | 2.04 | 85,100 | 173,604 | 85,100 | |
| Jun 18 2018 | PSDV | EyePoint Pharmaceu ... | Ross Leonard S | See Remarks | Option Exercise | A | 0.00 | 21,300 | 0 | 21,300 | |
| May 16 2018 | PSDV | EyePoint Pharmaceu ... | BLUM LEONARD M | See Remarks | Option Exercise | A | 1.95 | 65,000 | 126,750 | 65,000 | |
| May 16 2018 | PSDV | EyePoint Pharmaceu ... | BLUM LEONARD M | See Remarks | Option Exercise | A | 1.95 | 375,000 | 731,250 | 375,000 | |
| May 14 2018 | PSDV | EyePoint Pharmaceu ... | Barry James J | Director | Option Exercise | M | 0.00 | 12,500 | 0 | 0 |